AbbVie (ABBV) Accumulated Expenses (2012 - 2015)

AbbVie (ABBV) has reported Accumulated Expenses for 4 consecutive years, with $632.0 million the latest figure, recorded in Q4 2015.

• On a quarterly basis, Accumulated Expenses rose 1.44% year-over-year to $632.0 million in Q4 2015; TTM through Dec 2015 was $632.0 million, a 1.44% increase from a year earlier, with the FY2015 full-year figure at $632.0 million, up 1.44% from the prior year.
• Accumulated Expenses was $632.0 million for Q4 2015 at AbbVie, up from $623.0 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $632.0 million in Q4 2015 and troughed at $523.0 million in Q4 2012.
• A 4-year average of $599.8 million and a median of $622.0 million in 2013 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses grew 18.74% in 2013 and climbed 0.32% in 2014, its largest moves.
• Over 4 years, Accumulated Expenses stood at $523.0 million in 2012, then climbed by 18.74% to $621.0 million in 2013, then climbed by 0.32% to $623.0 million in 2014, then rose by 1.44% to $632.0 million in 2015.
• The last three Accumulated Expenses figures came in at $632.0 million (Q4 2015), $623.0 million (Q4 2014), and $621.0 million (Q4 2013), per Business Quant data.